Blood Borne Viruse Infections
Aptima®HIV-1 Quant Dx Assay
With performance you can count on, the Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management. Running on the Panther® system, Aptima HIV-1 Quant Dx accurately detects and monitors HIV-1 for reliable, repeatable results.
Aptima® HCV Quant Dx Assay
Confirmation of active HCV infection and monitoring HCV viral load on the fully automated Panther® system. Detects and quantitates HCV RNA genotypes 1, 2, 3, 4, 5, and 6.
Aptim® HBV Quant Assay
Deliver trusted results with dual targets across a wide linear range and all major HBV genotypes. The Aptima® HBV Quant Assay is a molecular HBV treatment management assay with dual-target design. It helps providers guide treatment management for patients with chronic hepatitis B infection who are undergoing antiviral therapy.
Aptima® CMV Quant Assay
Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. CMV, a member of the herpes virus family, establishes a lifelong latent infection that is generally asymptomatic. FDA-Approved solution to reliably and efficiently deliver actionable viral load insights to post-transplant patients and their care teams.
